204 related articles for article (PubMed ID: 21627048)
1. Prospects for epigenetic compounds in the treatment of autoimmune disease.
Chapman-Rothe N; Brown R
Adv Exp Med Biol; 2011; 711():150-61. PubMed ID: 21627048
[TBL] [Abstract][Full Text] [Related]
2. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic therapeutics in autoimmune disease.
Szyf M
Clin Rev Allergy Immunol; 2010 Aug; 39(1):62-77. PubMed ID: 19644776
[TBL] [Abstract][Full Text] [Related]
4. The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
Bronner C; Chataigneau T; Schini-Kerth VB; Landry Y
Curr Med Chem; 2007; 14(25):2629-41. PubMed ID: 17979715
[TBL] [Abstract][Full Text] [Related]
5. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
6. Current limitations and future opportunities for epigenetic therapies.
Cherblanc F; Chapman-Rothe N; Brown R; Fuchter MJ
Future Med Chem; 2012 Mar; 4(4):425-46. PubMed ID: 22416773
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
8. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
Rondelet G; Wouters J
Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapy for breast cancer.
Cai FF; Kohler C; Zhang B; Wang MH; Chen WJ; Zhong XY
Int J Mol Sci; 2011; 12(7):4465-87. PubMed ID: 21845090
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic-based therapies in cancer: progress to date.
Song SH; Han SW; Bang YJ
Drugs; 2011 Dec; 71(18):2391-403. PubMed ID: 22141383
[TBL] [Abstract][Full Text] [Related]
11. Interactions between core histone marks and DNA methyltransferases predict DNA methylation patterns observed in human cells and tissues.
Fu K; Bonora G; Pellegrini M
Epigenetics; 2020 Mar; 15(3):272-282. PubMed ID: 31509087
[TBL] [Abstract][Full Text] [Related]
12. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
Mapelli P; Aboagye EO; Stebbing J; Sharma R
Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
[TBL] [Abstract][Full Text] [Related]
15. Current and potential epigenetic targets in multiple myeloma.
Pawlyn C; Kaiser MF; Davies FE; Morgan GJ
Epigenomics; 2014 Apr; 6(2):215-28. PubMed ID: 24811790
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
Katarzyna R; Lucyna B
J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
[TBL] [Abstract][Full Text] [Related]
17. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
Shukla S; Penta D; Mondal P; Meeran SM
Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
[TBL] [Abstract][Full Text] [Related]
19. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
